Coventry LPC



July 10, 2020 News

Pharmacies have recently been contacted by NHSBSA by email asking them to submit data about their staff risk assessment status. The data is being collected online through the following LINK.  There’s a guidance document, which you can find HERE.

The data need to be submitted during the following periods:

  • 9am on 9th July to 11.59pm on 17th July; and
  • 9am on 24th July to 11.59pm on 31st July

Please note: Contractors are asked to submit a declaration in each window, even if all staff risk assessments were completed during the first.

A collection of resources for conducting the staff risk assessments can be found on the LPC website HERE.

Further resources can be found on the PSNC website HERE.


July 7, 2020 News

Please remember that Virtual Outlines pharmacy training is still available until the end of August. Funding is not likely beyond this date, so we recommend you take advantage of the available modules while you can.

You can find information and log-in advice on our  Virtual Outcomes page:

There are dozens of training modules available incuding immunisation, memengitis, dementia and many other public health topics and most recently the COVID 19 BUSINESS RESILIENCE TRAINING.

All you need to do is log in with your pharmacy F-code and select the modules you would like to view.


July 7, 2020 News

PSNC have extended the participation deadline for the Pharmacy Advice Audit to make sure no pharmacy misses out on the chance to submit their data – remember this can be used as your pharmacy choice of audits that have to be completed as part of  your contract.

Pharmacy teams now have until 10th July 2020 to capture information about the advice they give to their patients and local communities, and submit that data to PSNC via PharmOutcomes.

Further information and audit resources


July 3, 2020 News

PSNC has published a briefing to clarify how the Government’s NHS Test and Trace programme applies to community pharmacy to help reduce the need for large numbers of pharmacies needing to close.

This briefing provides further information on the programme, gives advice on patient and staff contacts, and outlines the relevant mitigations that may help to avoid the need for whole pharmacy teams to self-isolate if one member tests positive for COVID-19.

You can read the briefing below. If you require further information or clarification, please email

PSNC Briefing 022/20: NHS Test and Trace – Key points for contractors as Q&As (July 2020)




June 29, 2020 News

Pharmacy contractors will have received a letter from NHSE&I requesting the urgent completion of staff risk assessments within the next four weeks.

You can find a copy of this letter HERE.

We have compiled a list of resources on the LPC website to help you perform the staff risk assessment. You can also find further guidance on the PSNC website.


June 26, 2020 News

Reminder: Prescribe all insulins by brand

Following an incident, please be reminded of the guidelines below regarding insulin prescriptions.

 A number of new insulins have been launched in the UK including biosimilar insulins e.g. insulin glargine (brands include Abasaglar®, Lantus®, Semglee®, Toujeo®, Toujeo DoubleStar®), higher strength insulins e.g. Tresiba FlexTouch® (available as 100units/ml and 200units/ml strengths) and insulins with a similar name but with different strengths and/or different release profiles (e.g. Humulin M3®, Humulin I®, Humulin R® and Humulin S®).  Prescribing insulin by brand should ensure that substitution of a biosimilar insulin or alternative insulin product does not occur when the medicine is dispensed. Prescribing insulin by brand is recommended by the Medicines and Healthcare products Regulatory Authority (MHRA), Regional Medicines Optimisation Committee (RMOC), and the National Institute for Health and Care Excellence (NICE). Change from one insulin to another should be done with supervision and consent of the prescribing healthcare professional in consultation with the patient.

Action points:

  • For all new patients prescribed insulin, ensure prescribing/dispensing by brand name, that the device is specified and continuation of prescribing/dispensing of the same brand. This information should be included in patient documentation (e.g., insulin safety card/patient insulin passport).
  • Review all patients who are prescribed insulin generically. Clarify appropriate brand with the prescriber, confirming the current brand, e.g. with the patient.
  • The stability, shelf life and storage of the biosimilar insulin may differ from its reference product; therefore, check the Summary of Product Characteristics (SPC).
  • The insulin pen delivery device may be unique to the biosimilar insulin. Instruct patients on the correct use of the biosimilar pen device.
  • Consult the Coventry and Warwickshire APC net Formulary to check local formulary choices of insulins.


June 23, 2020 News

Community pharmacy contractors can now access guidance about the upcoming pharmacy advice clinical audit, including full details of how to take part in the audit.

As announced last week, community pharmacy teams are being encouraged to take part in an audit that will capture information about the advice they give to visitors to their pharmacy. The audit, which can be carried out as one of your contractual (clinical) audit for 2020/21, should be carried out on a single day in the week commencing Monday 29th June.

To successfully complete the audit, pharmacy teams will need to:

  1. Record patient/customer interactions where advice was given by either a non-pharmacist team member and/or a pharmacist.
  2. Carry this out for one whole day recording all consultations. (To be a valid audit, each pharmacy needs to achieve at least 20 consultations, therefore a small number will need to continue for a second day.)
  3. Estimate the percentage of consultations that were recorded during that time period (this is to recognise that some consultations may be missed).
  4. Rate your confidence in the advice given to help identify areas for improvement to reflect on post-audit.
  5. Enter the data on PharmOutcomes.

A team briefing sheet and audit template are now available to support contractors and their teams in preparing to undertake this audit. The briefing sheet sets out the criteria for inclusion, what needs to be recorded and how to reflect on your pharmacy’s results. It also answers some frequently asked questions as identified during testing with a small number of pharmacies. The audit template provides a simple way to record the required data, making things smoother for data entry onto PharmOutcomes

This audit will help demonstrate the added value your pharmacy team delivers and, alongside data from other pharmacies, will assist PSNC in gathering evidence to support the ongoing funding negotiations, including our call for more investment in the sector.

Audit resources

Team Briefing Sheet

Audit Template

Digital Guide


June 19, 2020 News

The findings and recommendations of the independent review into community pharmacy representation and support have been published.

The review was commissioned jointly by PSNC and LPCs last year to look for ways in which they could work more effectively together, and to ensure that the representation and support network for contractors – both local and national – is fit for the future.

The review was led by Professor David Wright, Professor of Pharmacy Practice at the University of East Anglia (UEA), working with a team of UEA researchers and taking evidence through focus groups, interviews and surveys from people across the community pharmacy sector and beyond.

You can find a summary of the recommendations and findings HERE.

PSNC has also published a Briefing, which you can find HERE.

You can read the full report HERE.

There’s also a contractor webinar hosted by Professor David Wright that you can attend on Monday 29th June at 7 pm. You can sign up HERE.

The LPC will examine the recommendations of the report and implement them accordingly.


June 17, 2020 News

PSNC is asking community pharmacy teams to take part in an audit that will capture information about all of the advice that pharmacies are giving to patients and local communities.

The audit has been tested by a small group of pharmacies to ensure it is easy to carry out, and it can be carried out as one of pharmacies’ contractual (clinical) audits for 2020/21. Pharmacies will be asked to carry out the audit on a single day in the week commencing Monday 29th June.

Apart from referrals via the Community Pharmacist Consultation Service (CPCS), patient consultations are not recorded anywhere, but from anecdotal reports we know that they are having a significant beneficial impact on local communities, patients and the wider NHS.

The audit will help us to assess how many of these informal consultations are happening and their positive impact on the patient and wider health care system, and this evidence will be used to support the ongoing funding negotiations, including PSNC’s ask for more investment in the sector.

Full details of how pharmacies can take part, including the audit template, guidance and a recorded presentation, will be available one week in advance of the audit week (on Monday 22nd June).

To find out more, please visit:


Providing information for Community Pharmacies about the work of the Local Pharmaceutical Committee and of the Community Pharmacy Services commissioned within Coventry


Copyright by Coventry LPC. All rights reserved.